Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: A systematic review

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Morgan, Catherine ^a,c   Zappitelli, Michael ^b   Gill, Peter ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CD11B ANTIGEN; CELL ADHESION MOLECULE; FLUINDOSTATIN; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SELECTIN; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OPEN HEART SURGERY; POSTOPERATIVE INFLAMMATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77949903653     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8135     Document Type: Article

References (33)

1. Carrascal Y, Guerrero AL, Maroto LC, Cortina JM, Rodriguez JE, Renes E, Rufilanchas JJ. Neurological complications after cardiopulmonary bypass: An update. Eur Neurol 1999, 41:128-134. 10.1159/000008035, 10202243.
2. Bove T, Calabro MG, Landoni G, Aletti G, Marino G, Crescenzi G, Rosica C, Zangrillo A. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 2004, 18:442-445. 10.1053/j.jvca.2004.05.021, 15365924.
3. Hill GE, Whitten CW, Landers DF. The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth 1997, 11:367-375. 10.1016/S1053-0770(97)90107-5, 9161906.
4. Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T. Heparin-bonded circuits versus nonheparin-bonded circuits: An evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 2007, 31:1058-1069. 10.1016/j.ejcts.2007.01.029, 17306555.
5. Robertson-Malt S, Afrane B, El Barbary M. Prophylactic steroids for pediatric open heart surgery. Cochrane Database Syst Rev 2007, 4:CD005550.
6. Rees K, Beranek-Stanley M, Burke M, Ebrahim S. Hypothermia to reduce neurological damage following coronary artery bypass surgery. Cochrane Database Syst Rev 2001, 1:CD002138.
7. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994, 108:636-641.
8. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993, 56:S92-S96.
9. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001, 21:1712-1719. 10.1161/hq1101.098486, 11701455.
10. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients. Eur Heart J 2008, 29:1548-1559. 10.1093/eurheartj/ehn198, 18506053.
11. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006, 105:1260-1272. 10.1097/00000542-200612000-00027, 17122590.
12. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality Of Reporting Of Meta-analyses. Lancet 1999, 354:1896-1900. 10.1016/S0140-6736(99)04149-5, 10584742.
13. Higgins JPT, Altman DG, . (editors) Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 (updated February 2008) 2008, The Cochrane Collaboration, (editors)., http://www.cochrane-handbook.org
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 192859, 12958120, 10.1136/bmj.327.7414.557.
15. Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, Sakata R. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006, 36:201-210. 10.1016/j.cyto.2006.11.001, 17300951.
16. Brull DJ, Sanders J, Rumley A, Lowe GD, Humphries SE, Montgomery HE. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol 2001, 88:431-433. 10.1016/S0002-9149(01)01696-4, 11545771.
17. Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Di Sciascio G, Covino E. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003, 89:538-543. 1767656, 12695460, 10.1136/heart.89.5.538.
18. Liakopoulos OJ, Dorge H, Schmitto JD, Nagorsnik U, Grabedunkel J, Schoendube FA. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006, 54:250-254. 10.1055/s-2006-923836, 16755446.
19. Wang XS, Mei YQ, Lu YF, Cai JZ, Ji Q, Tang CZ, Li TC, Hu DY. Influence of pravastatin on blood lipids and serum high sensitive C-reactive protein in patients undergoing conventional coronary artery bypass grafting under on-pump: A clinical study of 81 cases. Zhonghua Yi Xue Za Zhi 2008, 88:101-104.
20. Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, Di Sciascio G, Covino E. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg 2005, 28:805-810. 10.1016/j.ejcts.2005.09.013, 16274999.
21. Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, Chello M. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: A randomized controlled study. Clin Ther 2007, 29:1706-1717. 10.1016/j.clinthera.2007.08.010, 17919551.
22. Morawietz H, Erbs S, Holtz J, Schubert A, Krekler M, Goettsch W, Kuss O, Adams V, Lenk K, Mohr FW, Schuler G, Hambrecht R. Endothelial protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: The EPAS trial. Circulation 2006, 114(Suppl 1):I296-301.
23. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, . ARMYDA nvestigators Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004, 110:674-678. 10.1161/01.CIR.0000137828.06205.87, 15277322, ARMYDA nvestigators.
24. Tamayo E, Alonso O, Alvarez FJ, Castrodeza J, Florez S, Di Stefano S. Effects of simvastatin on acute-phase protein levels after cardiac surgery. Med Clin (Barc) 2008, 130:773-775. 10.1157/13121102, 18579030.
25. ANZCTR - Australian New Zealand Clinical Trials Registry. , http://www.anzctr.org.au/ACTRN12606000405516.aspx
26. ClinicalTrials.Gov. , http://clinicaltrials.gov/ct2/show/NCT00791648
27. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, Covino E. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 2007, 83:1374-1380. 10.1016/j.athoracsur.2006.10.065, 17383342.
28. Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: A novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2009, 57:91-95. 10.1055/s-2008-1039107, 19241310.
29. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw 2008, 19:99-103.
30. Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agro F, Carassiti M, Covino E. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006, 34:660-667. 10.1097/01.CCM.0000201407.89977.EA, 16505650.
31. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial. J Thorac Cardiovasc Surg 2008, 136:1541-1548. 10.1016/j.jtcvs.2008.06.038, 19114204.
32. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 2006, 114:1455-1461. 10.1161/CIRCULATIONAHA.106.621763, 17000910.
33. Florens E, Salvi S, Peynet J, Elbim C, Mallat Z, Bel A, Nguyen A, Tedgui A, Pasquier C, Menasche P. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. J Card Surg 2001, 16:232-239. 10.1111/j.1540-8191.2001.tb00513.x, 11824669.